Heparin, Low-Molecular-Weight
Showing 26 - 50 of >10,000
After Tissue Glue for Gastric Varices
Recruiting
- Anticoagulants and Bleeding Disorders
- +2 more
- Low molecular weight heparin
-
Jinan, Shandong, ChinaDepartment of Gastroenterology,Qilu Hospital,Shandong University
Sep 15, 2022
Critical Illness Trial (Nadroparin (intravenous Infusion), Nadroparin (subcutaneous group))
Completed
- Critical Illness
- Nadroparin (intravenous Infusion)
- Nadroparin (subcutaneous group)
- (no location specified)
Jul 19, 2021
Acute Coronary Syndrome Trial (A-Phase: tirofiban; Z-Phase simvastatin, Duration of Treatment: A-Phase: minimum suggested 48
Completed
- Acute Coronary Syndrome
- A-Phase: tirofiban; Z-Phase simvastatin
- +4 more
- (no location specified)
Feb 7, 2022
Adenomyosis, Assisted Reproductive Technology Trial in Nanjing (Low molecular weight heparin)
Active, not recruiting
- Adenomyosis
- Assisted Reproductive Technology
- Low molecular weight heparin
-
Nanjing, Jiangsu, ChinaReproductive Medicine Center, The affiliated Drum Towel Hospital
Feb 3, 2021
COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml
Recruiting
- COVID-19 Severe Respiratory Failure
- Dexamethasone
- +5 more
-
Alexandroupolis, Evros, GreeceUniversity Hospital of Alexandroupolis
Mar 11, 2022
Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)
Recruiting
- Severe Fever With Thrombocytopenia Syndrome
- Methylprednisolone
- +4 more
-
Guangshui, Hubei, China
- +9 more
Oct 31, 2022
Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low
Completed
- Rhegmatogenous Retinal Detachment
- High-risk for Proliferative Vitreoretinopathy (PVR)
- 5-fluorouracil and low molecular weight heparin
- Placebo
-
Freiburg, BW, Germany
- +12 more
Apr 4, 2022
Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular
Recruiting
- Cirrhosis
- +3 more
- Apixaban 2.5 MG
- +2 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College, Yangzhou University
Apr 30, 2022
Aspirin Thromboprophylaxis After First-line Total Hip and Knee
Recruiting
- Hip and Knee Prosthesis Implantation
-
Strasbourg, FranceService de Chirurgie Orthopédique Pédiatrique - Hôpitaux Univers
Nov 23, 2021
Cardiovascular Diseases, COVID-19 Trial in Boston (Enoxaparin)
Recruiting
- Cardiovascular Diseases
- COVID-19
-
Boston, MassachusettsAbdurahman Khalil
Feb 4, 2022
Diabetes, Type I Trial in Oslo, Stockholm, Uppsala (Low Molecular Weight Sulfated Dextran (LMW-SD), Heparin, CellCept®
Completed
- Diabetes Mellitus, Type I
- Low Molecular Weight Sulfated Dextran (LMW-SD)
- +8 more
-
Oslo, Norway
- +2 more
Sep 22, 2021
Pneumonia, Viral, Cytokine Storm Trial in Madrid, Valencia (radiation, device, drug)
Suspended
- Pneumonia, Viral
- Cytokine Storm
- Ultra-Low-dose radiotherapy
- +8 more
-
Madrid, Spain
- +1 more
Mar 14, 2022
Pregnancy, High Risk, Anticoagulants Trial in Orange (Lovenox)
Recruiting
- Pregnancy, High Risk
- Anticoagulants
-
Orange, CaliforniaUniversity of California Irvine
Apr 22, 2021
Pulmonary Embolism, Thoracic Surgery Trial in Shanghai (Chemoprophylaxis with Low Molecular Weight Heparin (LMWH))
Completed
- Pulmonary Embolism
- Thoracic Surgery
- Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 5, 2021
COVID-19 Pneumonia Trial in Jinan (Bevacizumab)
Recruiting
- COVID-19 Pneumonia
- Bevacizumab
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 13, 2023
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Thrombophlebitis Trial in Bologna, Piacenza (LMWH parnaparin subcutaneously)
Completed
- Thrombophlebitis
- LMWH parnaparin subcutaneously
-
Bologna, BO, Italy
- +1 more
Mar 18, 2021
Hepatic Artery Thrombosis, Liver Transplant; Complications, Pediatric Disease Trial in Shanghai (Ticagrelor Oral Tablet
Not yet recruiting
- Hepatic Artery Thrombosis
- +2 more
- Ticagrelor Oral Tablet [Brilinta]
- Low molecular weight heparin
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 23, 2021
Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)
Recruiting
- Anticoagulant
- +3 more
- Dalteparin Prefilled Syringe
- Tinzaparin profiled syringe
-
Copenhagen, Denmark
- +8 more
Aug 29, 2023
LMWH Compliance in Pregnancy
Recruiting
- Venous Thromboembolism
- Antenatal Deep Vein Thrombosis
- Smart sharps bin - collects data on compliance
-
Cork, IrelandCork University Maternity Hospital
Sep 23, 2021
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Blood Clot, Trauma Trial in Canada, United States (Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH))
Completed
- Blood Clot
- Trauma
- Acetylsalicylic acid
- Low Molecular Weight Heparin (LMWH)
-
Tucson, Arizona
- +20 more
Oct 7, 2022